eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | melanoma, malignant |
| Comorbidity | C0007099|carcinoma in situ |
| Sentences | 2 |
| PubMedID- 23990869 | Patients with previous invasive cancer within the past five years were ineligible, except for patients treated adequately for carcinoma in situ of the cervix or non-melanoma skin cancer. |
| PubMedID- 24699910 | Key exclusion criteria were as follows: prior chemotherapy, biologic therapy, or investigational therapy for locally recurrent breast cancer or mbc (prior endocrine therapy was permitted); prior malignancy (other than carcinoma in situ of the cervix or non-melanoma skin cancer) within 5 years; prior exposure to >360 mg/m2 doxorubicin or >720 mg/m2 epirubicin; inflammatory breast cancer; preexisting neuropathy of grade >2 (according to the national cancer institute [nci] common terminology criteria for adverse events [ctcae] version 4.0). |
Page: 1